STAT8d
In debate over obesity medications, FDA shifts toward importance of drugs in subtle ways
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
STAT2d
Demoting BMI, a new food label from the FDA, and risks of even moderate drinking
An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...
BioSpace10d
FDA Proposes Setting Bar for Weight-Loss Therapies as Obesity Space Heats Up
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...
FDA proposes warning label on front of food packaging to combat obesity epidemic
Packaged foods may soon have warning labels about how much sodium, saturated fats, and added sugars they contain in an effort ...
Lilly oral obesity drug could get FDA okay in early 2026: report
CEO Dave Ricks said Monday that the company's GLP-1 weight-loss pill orforglipron could receive FDA approval as soon as early ...
International panel offers new ways to define obesity
Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
FDA issues draft guidance on developing weight loss drugs
New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.